Cargando…
The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma
To explore the prognostic values of baseline 2‐deoxy‐2‐[(18)F] fluoro‐D‐glucose (FDG) positron emission tomography/computed tomography (PET/CT) dissemination parameter in angioimmunoblastic T‐cell lymphoma (AITL) and its added values to total metabolic tumour volume (TMTV). Eighty‐one AITL patients...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928789/ https://www.ncbi.nlm.nih.gov/pubmed/36819177 http://dx.doi.org/10.1002/jha2.610 |
_version_ | 1784888716610764800 |
---|---|
author | Gong, Huanyu Tang, Bo Li, Tiannv Li, Jianyong Tang, Lijun Ding, Chongyang |
author_facet | Gong, Huanyu Tang, Bo Li, Tiannv Li, Jianyong Tang, Lijun Ding, Chongyang |
author_sort | Gong, Huanyu |
collection | PubMed |
description | To explore the prognostic values of baseline 2‐deoxy‐2‐[(18)F] fluoro‐D‐glucose (FDG) positron emission tomography/computed tomography (PET/CT) dissemination parameter in angioimmunoblastic T‐cell lymphoma (AITL) and its added values to total metabolic tumour volume (TMTV). Eighty‐one AITL patients with at least two FDG‐avid lesions in baseline PET/CT were retrospectively included. PET parameters including TMTV and the distance between the two lesions that are the furthest apart (Dmax) were obtained. Univariate Cox analysis showed that both Dmax and TMTV were risk factors for progression‐free survival (PFS) and overall survival (OS). Multivariate Cox analysis models of different combinations showed that high Dmax (> 65.7 cm) could independently predict both PFS and OS, while high TMTV (>456.6 cm(3)) was only significant for OS. A concise PET model based on TMTV and Dmax can effectively risk‐stratify patients. PFS and OS rates were significantly lower in patients with high Dmax and high TMTV than in patients with low Dmax and low TMTV (3‐year PFS rate: 15.0% vs. 48.7%, p = 0.001; 3‐year OS rate: 27.6% vs. 79.0%, p < 0.001). Dmax can directly reflect the disease dissemination characteristic and has a significant prognostic value for FDG‐avid AITL patients. It has the potential to be introduced into new risk stratification models for tailored treatment. |
format | Online Article Text |
id | pubmed-9928789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99287892023-02-16 The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma Gong, Huanyu Tang, Bo Li, Tiannv Li, Jianyong Tang, Lijun Ding, Chongyang EJHaem Haematologic Malignancy ‐ Lymphoid To explore the prognostic values of baseline 2‐deoxy‐2‐[(18)F] fluoro‐D‐glucose (FDG) positron emission tomography/computed tomography (PET/CT) dissemination parameter in angioimmunoblastic T‐cell lymphoma (AITL) and its added values to total metabolic tumour volume (TMTV). Eighty‐one AITL patients with at least two FDG‐avid lesions in baseline PET/CT were retrospectively included. PET parameters including TMTV and the distance between the two lesions that are the furthest apart (Dmax) were obtained. Univariate Cox analysis showed that both Dmax and TMTV were risk factors for progression‐free survival (PFS) and overall survival (OS). Multivariate Cox analysis models of different combinations showed that high Dmax (> 65.7 cm) could independently predict both PFS and OS, while high TMTV (>456.6 cm(3)) was only significant for OS. A concise PET model based on TMTV and Dmax can effectively risk‐stratify patients. PFS and OS rates were significantly lower in patients with high Dmax and high TMTV than in patients with low Dmax and low TMTV (3‐year PFS rate: 15.0% vs. 48.7%, p = 0.001; 3‐year OS rate: 27.6% vs. 79.0%, p < 0.001). Dmax can directly reflect the disease dissemination characteristic and has a significant prognostic value for FDG‐avid AITL patients. It has the potential to be introduced into new risk stratification models for tailored treatment. John Wiley and Sons Inc. 2022-11-29 /pmc/articles/PMC9928789/ /pubmed/36819177 http://dx.doi.org/10.1002/jha2.610 Text en © 2022 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Haematologic Malignancy ‐ Lymphoid Gong, Huanyu Tang, Bo Li, Tiannv Li, Jianyong Tang, Lijun Ding, Chongyang The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma |
title | The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma |
title_full | The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma |
title_fullStr | The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma |
title_full_unstemmed | The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma |
title_short | The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma |
title_sort | added prognostic values of baseline pet dissemination parameter in patients with angioimmunoblastic t‐cell lymphoma |
topic | Haematologic Malignancy ‐ Lymphoid |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928789/ https://www.ncbi.nlm.nih.gov/pubmed/36819177 http://dx.doi.org/10.1002/jha2.610 |
work_keys_str_mv | AT gonghuanyu theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma AT tangbo theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma AT litiannv theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma AT lijianyong theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma AT tanglijun theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma AT dingchongyang theaddedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma AT gonghuanyu addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma AT tangbo addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma AT litiannv addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma AT lijianyong addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma AT tanglijun addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma AT dingchongyang addedprognosticvaluesofbaselinepetdisseminationparameterinpatientswithangioimmunoblastictcelllymphoma |